4 Pharma Majors Invest In ABCD Technologies

New Delhi : Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies LLP which will be renamed as IndoHealth Services LLP. The four pharma majors are investing Rs 40 crore each in the target entity which is a recently incorporated limited liability partnership and has not commenced any business activities, they added.

Sun Pharma and Cadila Healthcare said one of the wholly owned Indian subsidiaries have subscribed to partnership interest in ABCD Technologies LLP.

The objective of the acquisition is to facilitate, enable and promote efficiency and good distribution practices, including digitising healthcare infrastructure in India, inter alia, in support of the National Digital Health Mission of Government of India, the regulatory filings said.

The nature of consideration is cash infusion as capital contribution and Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma are investing Rs 40 crore each in the target entity, they added.

While Sun Pharma and Cadila Healthcare said that Rs 40 crore is for 20 per cent share of profit/ loss in the target entity, Lupin and Torrent Pharma said Rs 40 crore is for up to 20 per cent share of profit/loss in the target entity.

  • Related Posts

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India Limited has set up its new corporate office in Mumbai, marking an extension of company’s presence in India, reinforcing its ambition to transforming care by unlocking the…

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Exports of drugs and pharmaceuticals from the country have reported a growth of around 4.9% during the first six months of the current fiscal year, at $16.13 billion, as compared…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested